PT Millennium Pharmacon International Tbk (IDX:SDPC)
Indonesia · Delayed Price · Currency is IDR 200.00
0.00 (0.00%)
Sep 2, 2026, 11:37 AM WIB
IDX:SDPC Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 254,800 | 197,470 | 168,168 | 201,292 | 422,968 | 173,264 | |
Market Cap Growth | 51.52% | 17.42% | -16.46% | -52.41% | 144.12% | 30.77% |
Enterprise Value | 1,168,967 | 1,007,881 | 1,032,474 | 932,951 | 950,572 | 820,648 |
Last Close Price | 200.00 | 152.18 | 127.59 | 149.83 | 310.20 | 126.11 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.17 | 5.13 | 9.93 | 6.08 | 17.29 | 18.10 |
PS Ratio | 0.06 | 0.05 | 0.04 | 0.06 | 0.13 | 0.06 |
PB Ratio | 0.77 | 0.63 | 0.60 | 0.73 | 1.63 | 0.73 |
P/TBV Ratio | 0.78 | 0.64 | 0.61 | 0.75 | 1.69 | 0.73 |
P/FCF Ratio | - | 3.92 | - | - | - | - |
P/OCF Ratio | - | 2.24 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.27 | 0.25 | 0.26 | 0.28 | 0.30 | 0.28 |
EV/EBITDA Ratio | 8.38 | 8.19 | 9.65 | 9.41 | 11.90 | 12.88 |
EV/EBIT Ratio | 9.84 | 8.88 | 10.71 | 10.06 | 12.86 | 14.28 |
EV/FCF Ratio | - | 20.02 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.86 | 2.57 | 3.00 | 2.56 | 2.40 | 2.18 |
Debt / EBITDA Ratio | 6.79 | 5.98 | 7.14 | 6.43 | 6.93 | 7.05 |
Debt / FCF Ratio | - | 16.09 | - | - | - | - |
Net Debt / Equity Ratio | 2.76 | 2.37 | 2.81 | 2.35 | 2.30 | 1.98 |
Net Debt / EBITDA Ratio | 7.18 | 6.07 | 7.41 | 6.57 | 7.47 | 7.37 |
Net Debt / FCF Ratio | -5.58 | 14.84 | -5.68 | -5.84 | -5.17 | -20.72 |
Asset Turnover | 2.16 | 2.20 | 2.30 | 2.21 | 2.46 | 2.52 |
Inventory Turnover | 6.52 | 6.37 | 6.50 | 5.72 | 5.92 | 6.53 |
Quick Ratio | 0.60 | 0.58 | 0.56 | 0.58 | 0.53 | 0.54 |
Current Ratio | 1.11 | 1.11 | 1.11 | 1.13 | 1.13 | 1.14 |
Return on Equity (ROE) | 13.15% | 12.87% | 6.04% | 12.33% | 9.87% | 4.11% |
Return on Assets (ROA) | 3.72% | 3.80% | 3.53% | 3.81% | 3.54% | 3.03% |
Return on Invested Capital (ROIC) | 7.30% | 8.36% | 5.87% | 7.17% | 6.35% | 4.58% |
Return on Capital Employed (ROCE) | 28.50% | 28.00% | 26.90% | 26.30% | 25.60% | 21.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 16.20% | 19.48% | 10.07% | 16.44% | 5.78% | 5.52% |
FCF Yield | -64.31% | 25.49% | -83.02% | -55.44% | -27.26% | -13.07% |
Dividend Yield | 1.08% | - | 1.57% | 1.67% | 0.65% | 0.79% |
Payout Ratio | 14.69% | 6.60% | 18.81% | 7.70% | 5.21% | 6.65% |
Total Shareholder Return | 1.08% | - | 1.57% | 1.67% | 0.65% | 0.79% |